Polymerase chain reaction-based assessment after macrofilaricidal therapy in Onchocerca volvulus infection

Journal of Infectious Diseases

Volumn 173, Issue 3, 1996, Pages 773-776

  Nutman, Thomas B ^a   Wilson Parredes, Y ^b   Kubofcik, Joseph ^b   Guderian, Ronald H ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOCARZINE; ANTIFILARIAL AGENT; DNA;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; ONCHOCERCA VOLVULUS; ONCHOCERCIASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN;

EID: 19144364503     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/173.3.773     Document Type: Article

References (5)

1. WHO Expert Committee on Onchocerciasis. Third report. WHO Tech Rep Ser 1987;752:3-167.
2. Collins RC, Lehmann T, Vieira JC, Guderian RH. Vector competence of Simulium exiguum for Onchocerca volvulus: implications for the epidemiology of onchocerciasis. Am J Trop Med Hyg 1995;52:213-8.
3. Weiss N, Karam M. Humoral immune responses in human onchocerciasis: detection of serum antibodies in early infections. Ciba Found Symp 1987;127:180-8.
4. Ramachandran CP. Improved immunodiagnostic tests to monitor onchocerciasis control programmes - a multicenter effort. Parasitol Today 1993;9:76-9.
5. Meredith SEO, Unnasch TR, Karam M, Piessens WF, Wirth DF. Cloning and characterization of an Onchocerca volvulus-specific DNA sequence. Mol Biochem Parasitol 1989;36:1-10.